awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26777429-98C54E92-431A-40E8-95D0-BB2FB8D799DD
Q26777429-98C54E92-431A-40E8-95D0-BB2FB8D799DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777429-98C54E92-431A-40E8-95D0-BB2FB8D799DD
Current stage in inflammatory bowel disease: What is next?
P2860
Q26777429-98C54E92-431A-40E8-95D0-BB2FB8D799DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777429-98C54E92-431A-40E8-95D0-BB2FB8D799DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7128e44cfdf8c99c1d3fa4c1c60c9c013fbcff44
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.